Literature DB >> 20443127

Cardiac sympathetic denervation precedes nigrostriatal loss in the E46K mutation of the alpha-synuclein gene (SNCA).

B Tijero1, J C Gomez-Esteban, V Llorens, E Lezcano, M C Gonzalez-Fernández, M Martinez de Pancorbo, J Ruiz-Martinez, J C Cembellin, J J Zarranz.   

Abstract

INTRODUCTION: Here we report the case of an asymptomatic carrier of the E46K substitution in alpha-synuclein gene where we have documented that cardiac sympathetic denervation precedes nigrostriatal dopaminergic loss.
MATERIAL AND METHODS: She has been followed up regularly with standard neurological examination, UPDRS, neuropsychological formal testing, parkinson disease sleep scale-PDSS, Epworth scale, Hamilton-D scale, SCOPA Aut, orthostatic hypotension test, brief smell identification test, polysomnography, cerebral 123-I-FP-CIT SPECT, and, 123I-MIBG cardiac scintigraphy.
RESULTS: She shows no presence of orthostatic hypotension. Olfactory test results demonstrate normal limits. In the PSG the nocturnal sleep shows mild abnormalities although the sleep efficiency and stage proportion remain under normal limits. The 123-I-FP-CIT SPECT is normal; in contrast, the 123I-MIBG cardiac scintigraphy shows a complete lack of isotopic uptake compatible with a severe sympathetic myocardial denervation.
CONCLUSION: This example of monogenic autosomal dominant parkinsonism due to an alpha-synuclein mutation favours the hypothesis that peripheral autonomous nervous system involvement occurs earlier than the CNS degeneration.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20443127     DOI: 10.1007/s10286-010-0068-4

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  10 in total

Review 1.  Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages).

Authors:  Heiko Braak; Kelly Del Tredici; Hansjürgen Bratzke; John Hamm-Clement; Daniele Sandmann-Keil; Udo Rüb
Journal:  J Neurol       Date:  2002-10       Impact factor: 4.849

2.  The impact of the E46K mutation on the properties of alpha-synuclein in its monomeric and oligomeric states.

Authors:  Ross A Fredenburg; Carla Rospigliosi; Robin K Meray; Jeffrey C Kessler; Hilal A Lashuel; David Eliezer; Peter T Lansbury
Journal:  Biochemistry       Date:  2007-05-26       Impact factor: 3.162

3.  Cardiac sympathetic denervation from the early stage of Parkinson's disease: clinical and experimental studies with radiolabeled MIBG.

Authors:  H Takatsu; H Nishida; H Matsuo; S Watanabe; K Nagashima; H Wada; T Noda; K Nishigaki; H Fujiwara
Journal:  J Nucl Med       Date:  2000-01       Impact factor: 10.057

4.  Abnormal sleep architecture is an early feature in the E46K familial synucleinopathy.

Authors:  Juan J Zarranz; Anabel Fernández-Bedoya; Imanol Lambarri; Juan C Gómez-Esteban; Elena Lezcano; Javier Zamacona; Pedro Madoz
Journal:  Mov Disord       Date:  2005-10       Impact factor: 10.338

5.  Diagnostic accuracy of cardiac metaiodobenzylguanidine scintigraphy in Parkinson disease.

Authors:  H Sawada; T Oeda; K Yamamoto; N Kitagawa; E Mizuta; R Hosokawa; M Ohba; R Nishio; K Yamakawa; H Takeuchi; S Shimohama; R Takahashi; T Kawamura
Journal:  Eur J Neurol       Date:  2009-02       Impact factor: 6.089

Review 6.  Are Parkinson's disease with dementia and dementia with Lewy bodies the same entity?

Authors:  Dag Aarsland; C G Ballard; Glenda Halliday
Journal:  J Geriatr Psychiatry Neurol       Date:  2004-09       Impact factor: 2.680

7.  Autonomic failure as the initial presentation of Parkinson disease and dementia with Lewy bodies.

Authors:  Horacio Kaufmann; Kirsty Nahm; Dushyant Purohit; David Wolfe
Journal:  Neurology       Date:  2004-09-28       Impact factor: 9.910

Review 8.  A critical reappraisal of current staging of Lewy-related pathology in human brain.

Authors:  Kurt A Jellinger
Journal:  Acta Neuropathol       Date:  2008-07-01       Impact factor: 17.088

9.  The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia.

Authors:  Juan J Zarranz; Javier Alegre; Juan C Gómez-Esteban; Elena Lezcano; Raquel Ros; Israel Ampuero; Lídice Vidal; Janet Hoenicka; Olga Rodriguez; Begoña Atarés; Verónica Llorens; Estrella Gomez Tortosa; Teodoro del Ser; David G Muñoz; Justo G de Yebenes
Journal:  Ann Neurol       Date:  2004-02       Impact factor: 10.422

10.  Do alpha-synuclein aggregates in autonomic plexuses predate Lewy body disorders?: a cohort study.

Authors:  A Minguez-Castellanos; C E Chamorro; F Escamilla-Sevilla; A Ortega-Moreno; A C Rebollo; M Gomez-Rio; A Concha; D G Munoz
Journal:  Neurology       Date:  2007-06-05       Impact factor: 9.910

  10 in total
  11 in total

1.  Cardiocirculatory manifestations in Parkinson's disease patients without orthostatic hypotension.

Authors:  T Pérez; B Tijero; I Gabilondo; A Luna; V Llorens; K Berganzo; M Acera; A Gonzalez; A Sanchez-Ferro; E Lezcano; J J Zarranz; J C Gómez-Esteban
Journal:  J Hum Hypertens       Date:  2015-01-29       Impact factor: 3.012

Review 2.  Olfaction in Parkinson's disease and related disorders.

Authors:  Richard L Doty
Journal:  Neurobiol Dis       Date:  2011-12-20       Impact factor: 5.996

3.  Sympathetic noradrenergic before striatal dopaminergic denervation: relevance to Braak staging of synucleinopathy.

Authors:  David S Goldstein; Courtney Holmes; Latoya Sewell; Mee Yeong Park; Yehonatan Sharabi
Journal:  Clin Auton Res       Date:  2011-07-28       Impact factor: 4.435

4.  Arrhythmia and cardiac defects are a feature of spinal muscular atrophy model mice.

Authors:  Christopher R Heier; Rosalba Satta; Cathleen Lutz; Christine J DiDonato
Journal:  Hum Mol Genet       Date:  2010-08-06       Impact factor: 6.150

Review 5.  Olfactory Dysfunction in Neurodegenerative Diseases.

Authors:  Concepció Marin; Dolores Vilas; Cristóbal Langdon; Isam Alobid; Mauricio López-Chacón; Antje Haehner; Thomas Hummel; Joaquim Mullol
Journal:  Curr Allergy Asthma Rep       Date:  2018-06-15       Impact factor: 4.806

Review 6.  Vesicular integrity in Parkinson's disease.

Authors:  Shawn P Alter; Gina M Lenzi; Alison I Bernstein; Gary W Miller
Journal:  Curr Neurol Neurosci Rep       Date:  2013-07       Impact factor: 5.081

7.  Neuropathology and neurochemistry of nonmotor symptoms in Parkinson's disease.

Authors:  Isidro Ferrer
Journal:  Parkinsons Dis       Date:  2011-02-17

Review 8.  (123)I-Metaiodobenzylguanidine Myocardial Scintigraphy in Lewy Body-Related Disorders: A Literature Review.

Authors:  Eun Joo Chung; Sang Jin Kim
Journal:  J Mov Disord       Date:  2015-05-31

9.  The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases.

Authors:  Nolwen L Rey; Daniel W Wesson; Patrik Brundin
Journal:  Neurobiol Dis       Date:  2016-12-20       Impact factor: 5.996

Review 10.  Brain-First versus Gut-First Parkinson's Disease: A Hypothesis.

Authors:  Per Borghammer; Nathalie Van Den Berge
Journal:  J Parkinsons Dis       Date:  2019       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.